A Prospective Observational Study of Biologic Treatment and Outcomes in Patients With Severe Asthma (BREATH)
A Prospective Observational Study of Biologic Treatment and Outcomes in Patients With Severe Asthma (BREATH)
This study aims to evaluate the immunogenicity of the drug by measuring anti-drug antibody (ADA) formation and titers. The presence of ADAs will be assesses to determine their potential impact on the drug's efficacy and safety.
Inclusion Criteria:
Exclusion Criteria: